Cholestyramine

Ratio of specific activity relative to microsomes without added SI . Enzyme activities were determined as described in the Experimental section. Equal amounts of 100, 000g supernatant Sloe ; 300 pg ; protein from rats at normal lighting cycle SIOoN ; at and reversed lighting cycle with dietary supplement of 4.4% cholestyramine Slooc ; were added to each assay. Data are expressed as nmoles of 7a-hydroxycholesterol formed 20 min per mg microsomal protein. T h e mean of four independent experiments ? S.D. is presented. Abbreviations in parentheses denote source of microsomal preparation. FIRST GAZETTE NOTICES -CONTINUED. REECE & ROBERTS DEVELOPMENTS ; LIMITED REEDSPORT LIMITED REEL WORLD LIMITED REETHA LTD REFAL 113 LIMITED REGAL INTERIOR & BUILDING SERVICES LTD REGENCY DEVELOPMENTS UK ; LIMITED REGENT STREET NOTTINGHAM ; LIMITED REGINA FOOTWEAR LIMITED REGIS SECURITY LIMITED REID NICHOLLS ELECTRICAL LIMITED RELIABLE GARDENERS LIMITED RELIANCE LIMITED REMAT PACKAGING LIMITED REMEDION LIMITED REMEDY HEALTHCARE LIMITED RENAISSANCE ESTATES LIMITED RENDOR ENGINEERING LIMITED RENT A CAR ABROAD LTD RENWILLOWS LIMITED REP DESIGN LIMITED REPMORE 2008 LIMITED REPMORE 2005 LIMITED REPMORE 2004 LIMITED REPMORE 2009 LIMITED REPMORE 2001 LIMITED REPMORE 2007 LIMITED REPMORE 2006 LIMITED REPMORE 2003 LIMITED REPMORE 2002 LIMITED REPORTMARKET LIMITED REPUBLIQUE & EUROPE LIMITED RESEARCH & DEVELOPMENT PLANT LIMITED RESEARCH & SPECIAL PROJECTS INTERNATIONAL LIMITED RESERVE THAT HOUSE LTD RESONANCE MUSIC PRODUCTIONS LTD RESOURCE IP LIMITED RESOURCES IN TRAINING AND EDUCATION LIMITED RESOURCES 2000 UK LIMITED RESPONSE DESIGN ENGINEERING LIMITED RESPONSE EMPLOYMENT SERVICES LIMITED RES Q24 LIMITED RETAIL CONSULTANCY SOLUTIONS LIMITED RETPLAN INVESTMENTS LIMITED REVLAC-DG LTD REVOLUTION PROPERTY COMPANY LIMITED REVOLUTION PROPERTY SWINDON ; LIMITED REXBURG LIMITED REX CONTRACT SERVICES LIMITED REXLINK LTD R.G.HAIRSINE LIMITED R. GREENWAY BRICKWORK LIMITED R.G.S. MARKETING LTD. RHAZES EDUCATIONAL SERVICES LIMITED 02137532 05333383 05016529 R H CONSULTING TYTHERINGTON LIMITED RHETORICA LIMITED RHONDDA REGENERATIONS LIMITED RIAMBA LIMITED RICHARDS BAY LIMITED RICHARDSON AND KNIGHT LIMITED RICHARDS RADIO LIMITED RICHMOND UK ; LIMITED RICH SOLUTIONS LIMITED RICHYJAY SERVICES UK ; LIMITED RICK PAYNE FLOORING LIMITED RIDER VEHICLES LIMITED RIFTEC LIMITED RIGHT COMPUTERS LIMITED RIGHTFORM HOLDING LIMITED RIGHT HUNTING DEALS LIMITED RIGHTOPEN LIMITED RILLITO LIMITED RING A DINNER LIMITED RINGSIDE BOXING LTD RINJANI TRAINING LIMITED RIOTORUA LIMITED RISC 2005 LTD RISE CONSULTING LTD. RISE MEDIA LIMITED RISING SUN TAKEAWAY LIMITED RISK UK ; LIMITED RIVENTI LTD RIVERBANK TANDOORI LIMITED THE RIVER BURE PROPERTY COMPANY LIMITED RIVERDEEP SYSTEMS LIMITED RIVERMONT LIMITED RIVERSIDE REST LIMITED RIVER VIEW COMPUTING LTD RIVIERA ASSOCIATES LTD RIVIERA MAYA LIMITED R J O BUILDER LIMITED RJ PHYSIOTHERAPY LIMITED R. J. P. TECHNICAL SERVICES LIMITED RK ACCOUNTANCY SERVICES LIMITED RKDA LTD RKS BUILDERS LIMITED RLB TRADE LIMITED RMD PRODUCTS LIMITED R M EXIT LTD R.M. HOPPS TRANSPORT LIMITED R M PROPERTIES GRIMSBY ; LIMITED RM REFURB LIMITED R N MOTORSPORTS LIMITED ROADHOUSE CONSULTANTS LIMITED ROADRUNNER TRANSPORT LIMITED ROBERT JAMES SERVICES LIMITED ROBERT K. ISAACS LIMITED ROBERT MITCHELL BUILDERS LIMITED ROBERT NICHOLAS STEELS ; LIMITED ROBERTSDALE LIMITED 05016877 05331506 05491296.

Data are given as number percentage ; of participants unless otherwise specified. By analysis of covariance for continuous variables with sex as a covariate ; , and by extended 2 test for categorical variables. Not including bile acidbinding resins participants taking cholestyramine or colestid were not randomized.
Chemicals Cholesterol 99% pure ; was obtained from Sigma Chemical Co. St. Louis, MO ; and used as supplied. p-Sitostanol was prepared by Dr. Doyle Daves2 by the catalytic hydrogenation of p-sitosterol obtained from Nutritional Biochemical Co. Irving, CA it was 91% p-sitosterol and 9% campesterol by gasliquid chromatographic analysis. NMR spectral analysis of the product showed that the reduction was complete. Cholestyramine Cuemid ; was obtained from Merck, Sharpe and Dohme3 West Point, PA ; . All other chemicals were of reagent grade and used as supplied. Lymph transport study. Geous for exposure analysis because they circulate throughout the body and thus provide an estimate of average whole-body exposure. In fact, the conceptual basis for this approach is the hypothesis that the extent of genetic damage in peripheral blood lymphocytes reflects critical events for mutagenic and carcinogenic processes in target tissues. Similarly, specific genetic changes may occur in smooth muscle cells of the wall, leading to restenosis, as suggested by an increased mutation rate of microsatellites in both primary and secondary restenotic atherosclerotic plaques 31 ; . It also possible that the observed DNA damage may increase apoptosis 22, 23 ; . However, a recent study suggested that restenotic intimal cells may be resistant to apoptosis 32 ; , and increased DNA synthesis has been observed after balloon angioplasty in an atherosclerotic rabbit model 33 ; . This evidence suggests that intimal hyperplasia of smooth muscle cells may be a result of their clonal growth in response to a mutagenic event, underscor. Binding activity of this fraction was also 1.5- to 2-fold higher in cytosol preparations from rats sacrificed at the mid-dark compared to themid-light phase, amounting to 28-36 and 2023 pmol pg of protein, respectively, for the liver cytosol and to 10-12 and 6-8 pmol pg of protein, respectively, for the heart cytosol. The specific binding capacities are under both conditions lower in heart than in liver, due to the relatively higher content of low M, proteins e.g. myoglobin ; of heart muscle Fig.5 ; . The small fatty acid-binding fraction of M, 1500-2000, which contains a fatty acid-binding peptide 3234 ; , did not show a significant diurnal rhythm Fig. 5 ; . The presence of such a peptide in heart cytosol was not earlier reported. The absence of albumin in our preparations is also confirmed by a very low palmitate binding activity of the fractions that correspond to its elution position Fig. 5 ; . These results show that the higher palmitate binding capacity per pg of protein of both the rat liver and heart cytosol during the dark relative to the light period can be attributed to a higher content of FABP or to anincreased availability of the fatty acid-binding site s ; on this protein. The former possibility is most likely since modulation of the hepatic content of FABP is known to occur in several conditions involving nutritional, hormonal, and pharmacological manipulations 4-9 ; , whereas no evidence is available on the regulation of the availability of the fatty acid-binding site s ; . By comparison of the maximal fatty acid binding by rat liver cytosolic proteins with the cytosolic FABP concentration as found by Ockner et al. 3 ; on the basis of quantitative radial immunodiffusion studies, we established earlier 20 ; that FABP possesses only one fatty acid-binding site per protein molecule. As FABP accounts for 7545% of the fatty acid binding of our cytosol preparations Fig. 5 ; and has M, a of 12, 000 3 ; , the cytosolic FABP concentration can be estimated from the maximal fatty acid binding Table I ; . It appears that in liver the cytosolic FABP concentration amounts to about 40 and 70 pg mg of protein at themid-light and the mid-dark phase of the light cycle, respectively, and in heart to about 35 and 80 rg mg of protein, respectively. Effect of Cholestyramine Feeding-In a previous study 35 and chondroitin.

In human in-vitro fertilization IVF ; embryo transfer, the in-vitro culture environment differs from in-vivo conditions in that the oxygen concentration is higher, and in such conditions the mouse embryos show a higher concentration of reactive oxygen species ROS ; in simple culture media. ROS are believed to cause damage to cell membranes and DNA fragmentation in somatic cells. This study was conducted to ascertain the level of H2O2 concentration within embryos and the morphological features of cell damage induced by H2O2. A total of 62 human oocytes and embryos 31 fragmented, 15 non-fragmented embryos, 16 unfertilized oocytes ; was obtained from the IVFembryo transfer programme. The relative intensity of H2O2 concentrations within embryos was measured using 2 , 7 dichlorodihydrofluorescein diacetate by Quanti cell 500 fluorescence imaging and DNA fragmentation was observed with transmission electron microscopy and an in-situ apoptosis detection kit. The H2O2 concentrations were significantly higher in fragmented embryos 72.21 9.62, mean SEM ; compared to non-fragmented embryos 31.30 3.50, P 0.05 ; and unfertilized oocytes 30.75 2.67, P 0.05 ; . Apoptosis was observed only in fragmented embryos, and was absent in non-fragmented embryos. Electron microscopic findings confirmed apoptotic bodies and cytoplasmic condensation in the fragmented blastomeres. We conclude that there is a direct relationship between increased H2O2 concentration and apoptosis, and that further studies should be undertaken to confirm these findings. Key words: apoptosis embryo fragmentation reactive oxygen species.

A large number of Education faculty members engage in research and teaching that have an international component. The majority of these and other Faculty initiatives are supported by the Coordinator of International Programs who seeks out international program opportunities, manages several projects, and works with the International Advisory Group and the Graduate Program Visiting Scholars' Committee. Highlights in the past year include: the appointment of a new seconded faculty member in International and Global Education; the introduction of a new undergraduate elective course, "Global Issues and Education"; the delivery of three programs to teacher candidates from the Hong Kong Institute and the University of East Illinois; the placement of five students in the new York Student Internship Summer Program; the presence of four exchange students from Germany and Jamaica; the participation of four visiting scholars from China, Australia, the U.S. and Sweden, as well as two Summer Institute scholars from California and Australia; the visit to teacher education classes by performers from Sri Lanka promoting peace education through the Arts. The Faculty's participation in the CIDA-funded PERU-PROMEB Development program for elementary educators and school administrators in rural Peru continued in 2004-2005. The program was delivered by four members of the Faculty of Education. ELIS an Immersion semester for 21 international secondary candidates was run in collaboration with YUELI; the Merkaz i.t. L'Morim professional development program for Jewish educators was expanded; and funds were raised by the Faculty of Education Student Association for the Wikondiek School in Kenya and for Tsunami Relief. Faculty members delivered papers on international projects at several conferences during the past year, and a number of these are to be published. The recent rise in the Canadian dollar had a significant impact on the extent of customized course offerings for 2004-2005. Two tenders for programs were unsuccessful because of cost consideration: the Hong Kong Institute's English Language Immersion Program planned for Fall 2004 and Languages International Program for Student Teachers, planned for summer 2005. This may continue to be a factor in the coming year. Plans for 2005-2006 include the implementation of a program of support for internationally trained teachers funding has been awarded to the Faculty by the Ministry of Training, Colleges and Universities the maintenance and forging of new relationships.
Tions will be required to achieve ideal LDL cholesterol values. Fortunately, effective combinations are available Table 3 ; . Individual available medications are described below, along with their indicated uses, followed by an integrated plan presented for the treatment of the hypercholesterolemic patient. Drugs commonly used to lower elevated LDL levels include the bile acid sequestering resins such as cholestyramine and colestipol hydrochloride ; , nicotinic acid, and the new and powerful HMG CoA reductase inhibitors such as lovastatin ; . Probucol and the fibratelike derivatives, such as gemfibrozil, are also used as adjunct therapy, usually in combination with other medication. Dosages and typical costs of commonly used hypolipidemic agents are summarized in Table 4 and clofibrate.
All the patients had been treated with simvastatin with 27.8% receiving 20 mg, 69.6% receiving 40 mg and 2.5% receiving 40 mg bd. Additional therapy with cholestyramine was taken by 44% of patients and 25% received additional micronized fenofibrate 200 mg. Cholestyramine therapy was taken on questioning as 2.38 g sachets day as opposed to the 48 g originally prescribed. Atorvastatin was prescribed at doses of 10 mg 29% ; , 20 mg 27% ; , 40 mg 19% ; and 80 mg 25. 142. Branchi A, Rovellini A, Sommariva D, Gugliandolo AG, Fasoli A. Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia. Thromb Haemostasis. 1993; 70: 241-243. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen Progestin Interventions PEPI ; Trial. JAMA. 1995; 273: 199-208. Bo M, Bonino F, Neirotti M, et al. Hemorheologic and coagulative pattern in hypercholesterolemic subjects treated with lipid-lowering drugs. Angiology. 1991; 42: 106-113. Mitropoulos KA, Armitage JM, Collins R, et al. Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. Eur Heart J. 1997; 18: 235241. Marais AD, Firth JC, Bateman ME, Byrnes P, Martens C, Mountney J. Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1997; 17: 15271531. Wierzbicki AS, Lumb PJ, Semra YK, Crook MA. Effect of atorvastatin on plasma fibrinogen. Lancet. 1998; 351: 569-570. Behague I, Poirier O, Nicaud V, et al. Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: the ECTIM Study. Circulation. 1996; 93: 440-449. Rosenson RS, Tangney CC, Hafner JM. Intraindividual variability of fibrinogen levels and cardiovascular risk profile. Arterioscler Thromb. 1994; 14: 1928-1932. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 1993; 342: 1076-1079. Hamsten A, Wiman B, De Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med. 1985; 313: 15571563. Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG, for the ECAT Study Group. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation. 1996; 94: 20572063. Bevilacqua M, Bettica P, Milani M, et al. Effect of fluvastatin on lipids and fibrinolysis in coronary artery disease. J Cardiol. 1997; 79: 84-87. Stein JH, Rosenson RS. Lipoprotein a ; and coronary heart disease. Arch Intern Med. 1997; 157: 1170-1176. Harpel PC, Gordon BR, Parker TS. Plasmin catalyzes binding of lipoprotein a ; to immobilized fibrinogen and fibrin. Proc Natl Acad Sci U S A. 1989; 86: 3847-3851. Leren TP, Hjermann I, Berg K, Leren P, Foss OP, Viksmoen L. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia. Atherosclerosis. 1988; 73: 135-141. Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp a ; levels. Circulation. 1989; 80: 1313-1319. Slunga L, Johnson O, Dahlen GH. Changes in Lp a ; lipoprotein levels during the treatment of hypercholesterolemia with simvastatin. Eur J Clin Pharmacol. 1992; 43: 369-373. Haffner S, Orchard T, Stein E, Schmidt D, LaBelle P. Effect of simvastatin on Lp a ; concentrations. Clin Cardiol. 1995; 18: 261-267. Hunninghake DB, Stein EA, Mellies MJ. Effects of one year of treatment with pravastatin, an HMG-CoA reductase inhibitor, on lipoprotein a ; . J Clin Pharmacol. 1993; 33: 574-580 and clorazepate and cholestyramine.

Cholestyramine acts like a microscopic vacuum cleaner sucking up certain body substances and even medicines. Therapy post-doctoral training at a cholestyramine organizations for working professionals and chondroitin. TRAUMATIC CORNEAL ABRASIONS Abrasions over 4mm may benefit from the use of TCLs, where the epithelium reportedly heals more quickly, compared to conventional methods of treatment, i.e. topical medication and eye pad. Action: The use of disposable lenses is indicated, particularly in the treatment of corneal erosions with good success. 6, 7, 10, cholestyramine should be given two to three hours apart from vancomycin to prevent it from binding with vancomycin.

PROCEDURES The clinical trial comprised 2 phases. Phase 1 was a double-blind, randomized study comparing the efficacy of 100 g of transdermal 17 -estradiol with placebo. The randomization scheme was externally controlled and based on a list of random numbers generated by computer. Of 176 subjects initially screened for the study, 71 40.3% ; met criteria for DSM-IV depressive disorders and for perimenopause. Eight patients were excluded due to the presence of psychotic symptoms n 3 ; , aggressive behavior n 2 ; , significant suicidal thoughts n 1 ; , and history of bipolar disorder with sporadic use of mood stabilizers n 2 ; . addition, 13 subjects declined enrollment in the clinical trial and or did not attend all screening visits. Thus, 50 patients 25 per arm ; were randomly assigned to treatment with either patches of 100 g of 17 -estradiol Systen Evorel; Janssen-Cilag Laboratories, ~ Sao Paulo, Brazil ; or identical placebo patches for 12 weeks phase 1 ; . During phase 1, subjects were evaluated every 4 weeks when depressive symptoms MADRS scores ; and somatic symptoms BKMI scores ; were reassessed. After phase 1, subjects underwent a 4-week washout period and were then reassessed. The evaluation after the washout period was aimed to examine differences between the course of depressive and somatic symptoms after treatment discontinuation. Measurements of serum levels of FSH and estradiol were repeated at week 12. To avoid compromising the double-blind design, the occurrence of menstrual bleeding spontaneous cycling and or bleeding secondary to estrogen use withdrawal ; was recorded by an independent gynecologist. The study psychiatrist remained unaware of these events. In addition, at the study entry, subjects were informed that menstrual bleeding could occur regardless of the type of treatment received. Forty-five 90% ; of the 50 randomized subjects completed 12 weeks of treatment phase 1 ; . Four subjects randomized to placebo patches dropped out of the study due to patch-related skin irritation n 1 ; , "poor response" n 2 ; , and nausea n 1 ; . One subject treated with estradiol dropped out because of adverse effects headaches and nausea ; . Two additional subjects 1 from each arm ; dropped out during the washout period due to increased depressive symptoms. STATISTICAL ANALYSIS Data were analyzed with the SPSS statistical software.24 Frequencies of categorical data were analyzed using the Pearson 2 test or Fisher exact test, when appropriate. The independent t test 2-tailed ; was used for between-group comparisons. A paired t test 2-tailed ; was used for withingroup comparisons. A preliminary exploratory study showed that the data were fit for parametric procedures. Of note, nonparametric analyses Mann-Whitney and Wilcoxon paired rank tests ; produced similar results data not shown ; . All efficacy results reported are on an intent-totreat basis in which the last observation was carried forward into all subsequent time points for patients who dropped out before the end of the study. Statistical significance was set at the .05 level. Data are presented as meanSD.
Immunotherapy for treatment of superficial bladder cancer. Instillation of BCG into the bladder at full dose is associated with cystitis 91% ; , hematuria 43% ; , low-grade fever 29% ; , and malaise 24% ; . In general, these side effects can be managed symptomatically and usually clear within 12 to 24 hours. Other, more serious adverse events include high uncontrollable fever, granulomatous prostatitis, and major hematuria, which are less common but may be dose limiting. BCG is contraindicated in patients who are immunosuppressed or have active tuberculosis.

Viral inhibition assay Viral inhibition titers for IFN-2b and derivatives were performed at PBL BioMedical Lab Piscataway, NJ ; using MDBK cells challenged with VSV according to procedures described by Rubinstein et al. 44 ; . Samples were tested in duplicate against an international reference standard human IFN-2b, NIH Reference Gxa01-901-535. Might work directly with pharmacy initiatives, we will cholestyramine bcop. A line-shaped breath weapon is 5 feet high, 5 feet wide, and 60 feet long. A cone-shaped breath weapon is 30 feet long. Dragon Variety * Breath Weapon Black Line of acid Blue Line of lightning Green Cone of corrosive gas acid ; Red Cone of fire White Cone of cold Brass Line of fire Bronze Line of lightning Copper Line of acid Gold Cone of fire Silver Cone of cold * Other varieties of dragon disciple are possible, using other dragon varieties as ancestors.

P-S-001 P-S-002 ANTIAPOPTOTIC SIGNALING BY TF FVIIA IS INHIBITED BY SIMVASTATIN M. berg * SE ; , M. Wickstrm, A. Siegbahn TISSUE FACTOR PATHWAY INHIBITOR TFPI ; POLYMORPHISMS, HORMONE REPLACEMENT THERAPY HRT ; AND RISK OF VENOUS THROMBOEMBOLISM VTE ; T. O. Andersen NO ; , E. Hoibraaten, A. L. Eilertsen, P. M. Sandset * TISSUE FACTOR PROCOAGULANT ACTIVITY LEVELS IN HUMAN BLOOD ARE ELEVATED BY WARFARIN R. R. Bach * US ; , J. Sun, L. A. Leis, G. J. Johnson THRESHOLD BEHAVIOR OF THE BLOOD CLOTTING SYSTEM ACTIVATED BY THE TISSUE FACTOR A. N. Balandina * RU ; , D. A. Kireev, M. A. Panteleev, I. I. Shmirev, A. M. Shibeko, F. I. Ataullakhanov GYNAECOLOGICAL BLEEDING IN CONGENITAL FACTOR VII DEFICIENCY A. Batorova * SK ; , J. Schved, G. Auerswald, F. Herrmann, F. Peyvandi, A. Dolce, F. Bernardi, G. Mariani, on behalf of the IF7SG TISSUE FACTOR AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN CORONARY ARTERY DISEASE: CORRELATION WITH THE SEVERITY OF ATHEROMATOSIS L. M. Lima BR ; , M. O. Sousa, L. M. S. Dusse, M. C. Lasmar, B. A. Lwaleed, M. G. Carvalho * HYPERACTIVE C-JUN N-TERMINAL KINASE ENHANCES VASCULAR TISSUE FACTOR EXPRESSION IN AGING J. M. Carvas * CH ; , C. Barandier, M. Xiu-Fen, Z. Yang 1, 25 OH ; 2D3 BLOCKS TNF-INDUCED MONOCYTIC TISSUE FACTOR EXPRESSION BY INHIBITION OF TRANSCRIPTION FACTORS AP-1 AND NF-KAPPAB J. Chung * JP ; , T. Koyama, M. Ohsawa, A. Shibamiya, A. Hoshi, S. Hirosawa THE INFLUENCE OF TISSUE FACTOR ON OESTROGEN RECEPTOR ALPHA EXPRESSION AND CELL INVASION IN BREAST CANCER CELLS M. E. W. Collier * UK ; , C. Li, A. Frentzou, C. Ettelaie IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION M. Davila * US ; , A. Amirkhosravi, E. Coll, L. Robles, M. Abdelrahim, J. Colon, J. Francis, C. H. Baker AT LOW CONCENTRATIONS OF TISSUE FACTOR, CIRCULATING MICROPARTICLES CAUSE A MARKED SHORTENING OF THE RECALCIFICATION TIMES OF PLASMA FROM NORMAL HEALTHY INDIVIDUALS O. Dotsenko UK ; , C. A. Goodwin * , M. F. Scully, A. K. Kakkar TFPI PLASMA LEVELS IN WOMEN WITH PRE-ECLAMPSIA L. M. S. Dusse * BR ; , M. G. Carvalho, A. J. Cooper, B. A. Lwaleed. SUMMARY Cholestyramine 12 g day ; was administered to four subjects with familial hypercholesterolemia type II ; for 12 to 15 days. Plasma cholesterol values fell by 24 to 28% in all subjects. Total endogenous fecal steroids increased from 2.0 to 2.5 times over the control values. This increment was mainly in the acidic fraction which increased from 1.4 to 6.5 times during treatment. The neutral steroid fraction showed a slight increase nonsignificant ; in two subjects and a significant increase P 0.05 ; in one subject. The total fecal steroid increment was considerably in excess of the decrement in plasma cholesterol, thus indicating either a ; a substantial increase in cholesterol synthesis, b ; a transfer of cholesterol from depots, or c ; both. Plasma cholesterol specific activity time curves showed a sharp increase in the slope immediately after the commencement of treatment, reflecting an increase in the rate of entry of unlabeled cholesterol into the readily miscible pool. Since cholestyramine did not change the absorption of the dietary cholesterol, the increase in the contribution of unlabeled cholesterol could only be from an increase in endogenous synthesis. In accordance with previous findings from this laboratory, no evidence of degradation of the steroid nucleus was detected during its passage through the gastrointestinal tract. Within the Hospital there is an active policy of streamlining women with threatening abortion involving rapid access to ultrasound examination to sort out those with non viable pregnancies, blighted ova and missed abortions ; . This allows earlier evacuation of the uterine contents with less morbidity. Hence the incidence of blood transfusions and infection remain low in the first trimester miscarriage group. In the second trimester miscarriage group, especially those with trophoblastic disease, problems are slightly more common. This may be associated with the increased use of chemical methods of termination. Blood loss in certain racial and ethnic groups in our Hospital population who are prone to pre-existing anaemia, ; remains a special problem. Long term follow up of miscarriage sequelae including psychological impact ; , are not carded in this report. Table 1 Types of abortion and treatment 1996-98.

OVERCONTROLLED SUBSTANCES COUNTIII INADEQUATECONTROLS controlover andaccountability for with failing to maintainaccurate is TheRespondent charged in 124.402 l ; a ; substances, violationof IowaCode$$ 124.308 3 ; , including controlled drugs, Code$ 6.7. 2005 ; and657IowaAdministrative and1554.15 2Xi ; SUBSTANCES LAWS COUNTIV - VIOLATION OF CONTROLLED laws, in violation substances of with a failureto complywith controlled Respondent charged is 2005 ; 657Iowa and and IowaCodeS4.306, 124.308, 124.402 155A.15 ; c ; Code$ 36.1 4 ; 0 ; . Administrative B. CIRCUMSTANCES are A. the supporting abovecharges setforth in Attachment Thecircumstances praysthata hearingbe held in this matterandthat the Board WHEREFORE, Complainant the underthe law. takesuchactionasit may deemto be appropriate.

From the * Division of Cardiology, Ospedale Civile di Asti, Asti, Italy; Department of Medicine, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany; Division of Cardiology, Haut-Leveque, Bordeaux-Pessac, France; Department of Cardiac Diseases, San Filippo Neri Hospital, Rome, Italy; and the Molecular Genetics and Experimental Cardiology Programs, Masonic Medical Research Laboratory, Utica, New York. Manuscript received December 17, 2003; revised manuscript received February 11, 2004, accepted February 17, 2004.